Wegovy® has been shown to help lower the risk of another heart attack, stroke, or death
In adults with obesity or overweight and known heart disease.
Study results
In a study of adults who had a heart attack, stroke, or peripheral arterial disease (PAD) who also had obesity or overweight, Wegovy® pen 2.4 mg significantly lowered their risk of having ANOTHER major life-threatening heart event.
Heart disease is a term for conditions that affect your heart and blood vessels. These can include a heart attack, stroke, or a condition where your blood vessels narrow, known as PAD. People with a history of heart disease and obesity or overweight are at a greater risk of a major cardiovascular event such as stroke, heart attack, or death.
For adults with known heart disease and obesity or with overweight
Wegovy® your way
Whether you and your healthcare provider choose a once-daily pill or a once-weekly injection, Wegovy® can help you lose weight and keep it off when used with a reduced-calorie diet and increased physical activity.
Get inspired by the real voices of Wegovy®
*Terry is a real Wegovy® patient and has been compensated for his time.
Want to learn more about the cost of your Wegovy® prescription?
Wegovy® has you covered. Whether you have insurance through your employer, the marketplace, Medicare, or no insurance, you can learn more about the costs of your Wegovy® prescription.
Insurance through employer or marketplace
If you're ready to ask for Wegovy® but want to first find out if your insurance covers it, you can use this simple online tool and check in minutes.
Before going to the pharmacy to get your prescription for Wegovy®, call your insurance company to find out:
Your cardiologist’s office or your pharmacist can help you fill out these forms.
Learn more about the savings program Novo Nordisk® offers for eligible, commercially insured patients taking Wegovy®.
Medicare
If you have Medicare, they may pay for Wegovy® if you have had a heart attack, stroke, or PAD, and obesity or overweight.
Talk to someone at your Medicare plan to find out:
Your cardiologist‘s office or your pharmacist can help you fill out these forms.
Learn more about Medicare coverage for Wegovy®.
You can also call to speak to a NovoCare® representative about your Wegovy® Medicare coverage at 1-888-809-3942 8:00 AM to 8:00 PM ET, Monday–Friday.
No insurance?
If you are uninsured, you still have options to save on the cost of Wegovy®.
Learn more about self-pay options offered through NovoCare® Pharmacy.
Visit NovoCare.com or speak with a NovoCare® representative about your Wegovy® coverage:
1-888-809-3942, Monday–Friday, 8 AM to 8 PM (ET)
Get answers to your questions about Wegovy®.
Wegovy® may cause serious side effects, including:
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Wegovy® may affect the way some medicines work and some medicines may affect the way Wegovy® works. Tell your healthcare provider if you are taking other medicines to treat diabetes, including sulfonylureas or insulin. Wegovy® slows stomach emptying and can affect medicines that need to pass through the stomach quickly.
Wegovy® may cause serious side effects, including:
The most common side effects of Wegovy® may include: nausea, diarrhea, vomiting, constipation, stomach (abdomen) pain, headache, tiredness (fatigue), upset stomach, dizziness, feeling bloated, belching, low blood sugar in people with type 2 diabetes, gas, stomach flu, heartburn, and runny nose or sore throat.
Please see Prescribing Information and Medication Guide for Wegovy®.
Wegovy® is a prescription medication.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
This site is intended for US patients only.
Wegovy® (semaglutide) injection 1.7 mg or 2.4 mg and Wegovy® (semaglutide) tablets 25 mg are prescription medicines used with a reduced calorie diet and increased physical activity to:
Wegovy® (semaglutide) injection 1.7 mg or 2.4 mg is used with a reduced-calorie diet and increased physical activity to help children 12 years and older with obesity to lose weight and keep the weight off
Wegovy® contains semaglutide and should not be used with other semaglutide-containing products or other GLP-1 receptor agonist medicines.
It is not known if Wegovy® injection is safe and effective:
It is not known if Wegovy® tablets are safe and effective for use in people under 18 years of age.
Wegovy® (semaglutide) injection 1.7 mg or 2.4 mg and Wegovy® (semaglutide) tablets 25 mg are prescription medicines used with a reduced calorie diet and increased physical activity to:
Wegovy® (semaglutide) injection 1.7 mg or 2.4 mg is used with a reduced-calorie diet and increased physical activity to help children 12 years and older with obesity to lose weight and keep the weight off
Wegovy® contains semaglutide and should not be used with other semaglutide-containing products or other GLP-1 receptor agonist medicines.
It is not known if Wegovy® injection is safe and effective:
It is not known if Wegovy® tablets are safe and effective for use in people under 18 years of age.
Wegovy® may cause serious side effects, including:
Wegovy® may cause serious side effects, including:
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Wegovy® may affect the way some medicines work and some medicines may affect the way Wegovy® works. Tell your healthcare provider if you are taking other medicines to treat diabetes, including sulfonylureas or insulin. Wegovy® slows stomach emptying and can affect medicines that need to pass through the stomach quickly.
Wegovy® may cause serious side effects, including:
The most common side effects of Wegovy® may include: nausea, diarrhea, vomiting, constipation, stomach (abdomen) pain, headache, tiredness (fatigue), upset stomach, dizziness, feeling bloated, belching, low blood sugar in people with type 2 diabetes, gas, stomach flu, heartburn, and runny nose or sore throat.
Please see Prescribing Information and Medication Guide for Wegovy®.
Wegovy® is a prescription medication.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
This site is intended for US patients only.
Wegovy® (semaglutide) injection 1.7 mg or 2.4 mg and Wegovy® (semaglutide) tablets 25 mg are prescription medicines used with a reduced calorie diet and increased physical activity to:
Wegovy® (semaglutide) injection 1.7 mg or 2.4 mg is used with a reduced-calorie diet and increased physical activity to help children 12 years and older with obesity to lose weight and keep the weight off
Wegovy® contains semaglutide and should not be used with other semaglutide-containing products or other GLP-1 receptor agonist medicines.
It is not known if Wegovy® injection is safe and effective:
It is not known if Wegovy® tablets are safe and effective for use in people under 18 years of age.